Aquilo Capital Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-41,290
Closed -$984K 15
2023
Q3
$984K Hold
41,290
0.89% 12
2023
Q2
$547K Sell
41,290
-15,621
-27% -$207K 0.3% 12
2023
Q1
$4.44M Hold
56,911
1.84% 11
2022
Q4
$4.73M Buy
56,911
+6,457
+13% +$537K 1.78% 12
2022
Q3
$4.64M Buy
50,454
+3,750
+8% +$345K 1.67% 13
2022
Q2
$6.99M Buy
46,704
+343
+0.7% +$51.3K 2.38% 9
2022
Q1
$11.2M Buy
46,361
+6,404
+16% +$1.55M 1.65% 10
2021
Q4
$12.1M Hold
39,957
1.37% 11
2021
Q3
$16.5M Hold
39,957
3% 11
2021
Q2
$12.2M Sell
39,957
-5,987
-13% -$1.83M 3.18% 11
2021
Q1
$9.45M Hold
45,944
1.71% 12
2020
Q4
$9.19M Hold
45,944
1.91% 11
2020
Q3
$7.61M Sell
45,944
-23,750
-34% -$3.93M 0.81% 10
2020
Q2
$17.3M Hold
69,694
3.49% 9
2020
Q1
$12.7M Buy
69,694
+7,609
+12% +$1.39M 4.95% 8
2019
Q4
$17.8M Buy
62,085
+25,107
+68% +$7.19M 6.67% 3
2019
Q3
$10.1M Buy
36,978
+18,830
+104% +$5.14M 7.1% 4
2019
Q2
$6.82M Buy
18,148
+3,013
+20% +$1.13M 2.37% 9
2019
Q1
$4.06M Hold
15,135
1.8% 9
2018
Q4
$3.22M Sell
15,135
-9,554
-39% -$2.03M 1.56% 12
2018
Q3
$11.1M Hold
24,689
4.63% 7
2018
Q2
$10M Buy
+24,689
New +$10M 8.26% 5